These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 20189787

  • 1. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD.
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
    [Abstract] [Full Text] [Related]

  • 2. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 3. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic fatty liver disease (NAFLD): a comprehensive review.
    Salt WB.
    J Insur Med; 2004 Jun; 36(1):27-41. PubMed ID: 15104027
    [Abstract] [Full Text] [Related]

  • 6. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF, Diehl AM.
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [Abstract] [Full Text] [Related]

  • 7. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Nov; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 9. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 10. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS.
    Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
    [Abstract] [Full Text] [Related]

  • 11. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ, Chitturi S, Heydet D, Farrell GC.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
    Pettinelli P, Obregón AM, Videla LA.
    Nutr Hosp; 2011 Apr; 26(3):441-50. PubMed ID: 21892559
    [Abstract] [Full Text] [Related]

  • 13. Non-alcoholic fatty liver disease.
    Smith BW, Adams LA.
    Crit Rev Clin Lab Sci; 2011 Apr; 48(3):97-113. PubMed ID: 21875310
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP.
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [Abstract] [Full Text] [Related]

  • 15. The potential role of genes in nonalcoholic fatty liver disease.
    Day CP.
    Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069
    [Abstract] [Full Text] [Related]

  • 16. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
    Yki-Järvinen H.
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006 Nov; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 18. The emerging problem of nonalcoholic steatohepatitis (NASH).
    Portincasa P, Grattagliano I, Palmieri VO, Palasciano G.
    Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
    [Abstract] [Full Text] [Related]

  • 19. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [Abstract] [Full Text] [Related]

  • 20. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.